AMLX Amylyx Pharmaceuticals, Inc.
$27.62
Amylyx Pharmaceuticals, Inc. (AMLX) Earnings News
Earnings press releases, previews and reviews for Amylyx Pharmaceuticals, Inc. (AMLX), newest first. Our most recent is review: Amylyx Matches Loss Estimate as Phase 3 Win and $545 Million Raise Shift the Story From Trial Risk to Launch Execution.
Thursday
November 5, 2026
9:47 AM ET
Amylyx Matches Loss Estimate as Phase 3 Win and $545 Million Raise Shift the Story From Trial Risk to Launch Execution
Earnings Whispers · Review
Thursday
November 5, 2026
7:00 AM ET
Amylyx Pharmaceuticals Reports Third Quarter 2026 Financial Results
Monday
November 2, 2026
9:49 AM ET
Amylyx Heads Into First Report Since Lucidity Readout Window as PBH Launch Questions Take Center Stage
Earnings Whispers · Preview
Monday
November 2, 2026
9:00 AM ET
Amylyx Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
Thursday
August 6, 2026
7:00 AM ET
Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results
Monday
August 3, 2026
9:00 AM ET
Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026